Brief: Sigilon Therapeutics Reports Fourth Quarter And Full Year 2020 Financial Results And Business Highlights
18/03/2021 21:24
March 18 (Reuters) - Sigilon Therapeutics, Inc. SGTX.O :
* SIGILON THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2020
FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
* SIGILON THERAPEUTICS, INC. - QTRLY LOSS PER SHARE $1.15
* SIGILON THERAPEUTICS, INC. - CASH WAS $202.2 MILLION AS OF
DECEMBER 31, 2020.
Source text for Eikon: ID:nGNXmhqHp
Further company coverage: SGTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sigilon Therapeutics
See all newsSigilon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Sigilon Therapeutics Inc expected to post a loss of $4.71 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Micron, Greenbrier, Immunome
Sigilon jumps on Eli Lilly's buyout deal to expand diabetes treatments
U.S. STOCKS ON THE MOVE-Sigilon, Netflix, RenovoRx